Journey Medical Corp. (DERM)
7.31
-0.05
(-0.68%)
USD |
NASDAQ |
Sep 18, 16:00
7.32
+0.01
(+0.14%)
Pre-Market: 20:00
Journey Medical Total Long Term Debt (Quarterly) : 25.47M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.47M |
| March 31, 2026 | 25.37M |
| December 31, 2025 | 25.30M |
| September 30, 2025 | 19.58M |
| June 30, 2025 | 21.43M |
| March 31, 2025 | 23.20M |
| December 31, 2024 | 25.00M |
| September 30, 2024 | 19.78M |
| June 30, 2024 | 19.75M |
| March 31, 2024 | 14.68M |
| December 31, 2023 | 14.63M |
| September 30, 2023 | 0.034M |
| June 30, 2023 | 1.549M |
| Date | Value |
|---|---|
| March 31, 2023 | 11.46M |
| December 31, 2022 | 21.35M |
| September 30, 2022 | 21.18M |
| June 30, 2022 | 18.60M |
| March 31, 2022 | 18.49M |
| December 31, 2021 | 3.627M |
| September 30, 2021 | 36.61M |
| June 30, 2021 | 19.58M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 8.234M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nektar Therapeutics | 113.23M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |
| Johnson & Johnson | 37.34B |